G01N 2333/96436
Granzymes
G01N2333/96436 (Granzymes) appears on 94 US grants and 63 published applications in this corpus.
Search patents in G01N- Granted patents
- 94
- Published applications
- 63
- Assignees
- 42
- Inventors
- 174
- Latest grant
- 2 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 15 | 0 |
| 1998 | 28 | 0 |
| 1999 | 4 | 0 |
| 2000 | 6 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 3 |
| 2004 | 3 | 2 |
| 2005 | 2 | 2 |
| 2006 | 1 | 2 |
| 2007 | 1 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 3 |
| 2011 | 2 | 1 |
| 2012 | 1 | 2 |
| 2013 | 1 | 3 |
| 2014 | 1 | 3 |
| 2015 | 2 | 4 |
| 2016 | 0 | 4 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 0 | 4 |
| 2021 | 2 | 3 |
| 2022 | 2 | 3 |
| 2023 | 2 | 0 |
| 2024 | 1 | 4 |
| 2025 | 2 | 4 |
| 2026 | 0 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for identifying epitopes2 Sep 2025US 12,404,503 B2The Brigham and Women S Hospital, Inc.
- Compositions and methods for logic-gated profiling of biologic activity24 Jun 2025US 12,338,483 B2Georgia Tech Research Corporation
- Molecular biomarkers for cancer immunotherapy26 Mar 2024US 11,939,637 B2Massachusetts Institute of Technology
- Methods and compositions for identifying epitopes5 Dec 2023US 11,834,653 B2The Brigham and Women S Hospital, Inc.
- Prediction of response to immune-modulatory therapies9 May 2023US 11,644,467 B2Yale University
- Humoral Immune Activators for the Treatment of Humoral Immunosuppressed Pathologies, Cancer and Infectious Disease and Humoral Immune Suppressors for the Treatment of Inflammatory Diseases3 Sep 2026US 2026/0256811 A1Navrogen, Inc.
- Affinity and functional based screening of t cell receptor repertoire using three-dimensional shaped particles30 Jul 2026US 2026/0218282 A1The Regents of the University of California
- Production and use of natural killer (nk) cell-derived extracellular vesicles for treatment of cancer and infectious disease14 May 2026US 2026/0130939 A1Saint Louis University
- Compositions and methods for logic-gated profiling of biologic activity30 Apr 2026US 2026/0117277 A1Georgia Tech Research Corporation
- Methods and compositions for identifying epitopes5 Feb 2026US 2026/0035688 A1The Brigham and Women S Hospital, Inc.
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997
- High-affinity nucleic acid ligands that discriminate between theophylline and caffeine277US 5,580,737 ANeXstar Pharmaceuticals, Inc. · 1996